Skip to content
logo

About

Dr. Ankur Phatarpekar is an accomplished Interventional Cardiologist and Structural Heart Specialist based in Mumbai, India. With a Doctorate in Medicine (D.M.) in Cardiology and extensive experience in the field, Dr. Phatarpekar has expertise in a wide range of interventional cardiology procedures, including pediatric device closures and complex structural heart interventions. He has also demonstrated proficiency in complex structural procedures such as rupture of sinus of Valsalva device closure and paravalvular leak device closure.

His notable achievements include being a National Faculty for various prestigious conferences, presenting complex cases and moderating sessions on topics like Optical Coherence Tomography (OCT) and Transcatheter Aortic Valve Implantation (TAVI). Dr. Phatarpekar has also been involved in significant clinical trials as a co-investigator, contributing to advancements in the field of cardiology.

Recognized for his contributions, Dr. Phatarpekar has received awards such as the Outstanding Young Person Award and has been actively involved in academic programs and orations. His publications and abstracts reflect his commitment to sharing knowledge and advancing cardiovascular care.

As a member of esteemed cardiovascular societies and associations, Dr. Phatarpekar continues to stay at the forefront of innovative practices in cardiology. His dedication to technology and innovation, as demonstrated by initiatives like utilizing social media for delivering acute coronary syndrome care, underscores his holistic approach to patient well-being and healthcare advancement.

Interest Areas

 
OPD consultations are available by appointment only. Patients are requested to book in advance to ensure a smooth and timely consultation.

 

Credentials

Positions

  • Current:
    • Consultant Cardiologist
    • Director Cardiac Services – Heart & Vascular Superspeciality Group of Hospitals
    • Director – Symbiosis Speciality Hospital
  • Previous:
    • Assistant Professor at King Edward Memorial Hospital, Mumbai – 2015-2017

Education & Training

  • Bachelor in Medicine and Bachelor in Surgery (M.B.B.S.) - Aug 2000 – Dec 2004
  • Doctor of Medicine (M.D.) - July 2007 – June 2010
  • Doctorate in Medicine (D.M.) Cardiology - June 2012 – July 2015
  • Fellow of Society of Cardiovascular Angiography & Interventions (FSCAI)

Proctor

  • Boston Scientific: Rota-ablation
  • Abbott: Optical Coherence Tomography - OCT
  • Meril: Certified TAVR Proctor — Myval transcatheter heart valve system
  • Boston Scientific: Transcatheter Aortic Valve Implantation – TAVI
Meril Myval certified TAVR proctor certificate awarded to Dr. Ankur Phatarpekar, 2026
Certified TAVR Proctor (2026) — Myval transcatheter heart valve system, Meril Life Sciences.

Membership

  • Society for Cardiovascular Angiography & Interventions
  • European Association of Percutaneous Cardiovascular Interventions (EAPCI)
  • American College of Cardiology
  • Cardiology Society of India

Published Papers

  • "Transcatheter closure of patent ductus arteriosus – experience with the ‘Direct duct technique’" - Journal of Cardiovascular Disease Research. 2016;7(3)123.
  • "Modified transjugular approach for percutaneous atrial septal defect closure" - Ann Pediatr Cardiol. 2017 May-Aug; 10(2): 197–199.
  • "Appropriateness of elective percutaneous coronary intervention and impact of government health insurance scheme A tertiary center experience from Western India" - Indian Heart J (2017).
  • "On your fingertips - a new aid to learn the anatomy of the secundum atrial septal defect" - Indian Heart Journal 68 (2016), pp. 366-367.
  • "Cardiac manifestations in Mucopolysaccharoidosis" - Indian Heart Journal 68 (2016), pp. 196-198.
  • "Is the Sac Waiting to Rupture? Sinus of Valsalva Aneurysm" - Aorta (Stamford). DOI 10.12945/ j.aorta.2016.15.027.
  • "Single Access Transcatheter Ventricular Septal Defect Closure through Trans radial Approach" - J CardiolClin Res 4(8) 1089.
  • “Neonatal diabetes mellitus due to L233F mutation in the KCNJ11 gene” - World J Pediatr 2011 Nov; 7(4):371-2.
  • “Haemophagocyticlymphohistiocytosis: A case series from Mumbai” - Ann Trop Paediatr 2011;31(2):35-40.
  • Propionic academia presenting as diabetic ketoacidosis” - Indian Paediatr 2011 Feb;48(2):164-5.
  • “Hypomagnesemia with secondary hypocalcemia due to TRPM6 gene mutation” - Sri Lanka Journal of Child Health, 2012; 41(4): 205-206.
  • “Endocrine abnormalities in children with beta-thalassemia major” - Sri Lanka College of Paediatrics, Vol. 42, June; 2013:81-7.

Abstracts

  • “To assess the immediate and mid-term outcome of transcatheter closure (TCC) in patients with Coronary Cameral Fistula (CCF)”- SCAI 2016 conference, Florida, United States of America.
  • “Appropriateness of elective PCI & impact of government health scheme – a tertiary center experience from western India” - Cardiological Society of India 2016 conference, Kochi, India.
  • “Immediate outcomes of balloon mitral valvotomy (BMV Procedure) for restenosis amongst patients with split mitral commissure” - Cardiological Society of India 2016 conference, Kochi, India.
  • “Outcomes of transcatheter closure using the Amplatzer devices in the largest series of patients with isolated aorto-pulmonary window” - European Society of Cardiology, London, UK. 2015.
  • “Medium-term follow-up of transcatheter closure of ruptured sinus of Valsalva aneurysm” - Pediatric Cardiology Society Of India, 2015.
  • “Coronary Sinus lead placement in the presence of coronary sinus dissection” - Cardiological Society of India 2014 conference, Hyderabad, India.
  • “15th International Pediatric Nephrology Association conference 2010” - New York, United States of America.
  • “Case series of fungal sepsis in neonates” - NeoCon India, Kolkata, India 2009.

Clinical Trials

  • RESTORE INDIA Trial : Real-world Evaluation of Safety and Therapeutic Outcomes of Repair using MyClip Transcatheter Edge-to-Edge repair system. Role: Principal Investigator
  • RMDL/VIVA INDIA Trial : A Prospective, Multicentric, Single-Arm, Open-Label, Post-Marketing Clinical Investigation to Evaluate the Safety and Effectiveness of Vienna Valve (Transcatheter Aortic Valve System) in Patients with Symptomatic Severe Aortic Stenosis. Role: Principal Investigator
  • SIRONITY PMCF Trial : A Post-Market Clinical Follow-up Study of the Sironity Sirolimus-Coated Balloon in Patients With In-Stent Restenosis or De Novo Small Vessel Coronary Lesions. Role: Co Investigator
  • MOZEC SEB Registry: A prospective, single-centre, single-arm registry to evaluate short and mid-term experience of Mozec™ SEB Sirolimus Eluting Rx PTCA Balloon Dilatation Catheter in patients with coronary artery disease. Role: Principal Investigator
  • A real-world evidence study to examine the effect of individualized follow-up of Smart Phone Application (SPA) based standard of care versus standard of care among the patients with Heart Failure (HF); LPDH_RWEHF001. Role: Principal Investigator
  • (IKISS LM trial) Impact of KISSing balloon inflation on provisional Left Main bifurcation percutaneous coronary intervention: A prospective multicenter randomized controlled trial. Role: Principal Investigator
  • ODYSSEY-OUTCOMES Trial: This trial evaluated the role of PCSK9 inhibitors in patients with acute coronary syndromes. Role: Co-investigator
  • FREEDOM eV Trial: This trial compared time-to-first-worsening in subjects with pulmonary arterial hypertension receiving various treatment combinations. Role: Co-investigator
Phone

Call

WhatsApp icon

Whatsapp